| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAAGCCAGCGAAGCACGGGCCCAACCGGGCCAUGUCGGGGGAGCCUGAG… | 1740 nt | 0.5879 | |
| AAAGCCAGCGAAGCACGGGCCCAACCGGGCCAUGUCGGGGGAGCCUGAG… | 1847 nt | 0.5939 | |
| GUGCUAGGCGAUAGAGAUCCAACUGUUGAGCAGGCCUCUCUGCCUGUGG… | 1676 nt | 0.5710 | |
| AGUCUUAACGGUUGCGGCGCGGCUCUGGCCCGGGCGCACGCGCACACUG… | 1737 nt | 0.5809 | |
| AAAGCCAGCGAAGCACGGGCCCAACCGGGCCAUGUCGGGGGAGCCUGAG… | 1859 nt | 0.5944 |
This gene encodes a protein similar to the RAS effector proteins. Loss or altered expression of this gene has been associated with the pathogenesis of a variety of cancers, which suggests the tumor suppressor function of this gene. The inactivation of this gene was found to be correlated with the hypermethylation of its CpG-island promoter region. The encoded protein was found to interact with DNA repair protein XPA. The protein was also shown to inhibit the accumulation of cyclin D1, and thus induce cell cycle arrest. Several alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, May 2011]
A study in human ovarian cancer samples identified the RASSF1 as a tumor suppressor gene with promoter hypermethylation, included in the DNA methylation dimension of a multi-dimensional module (md-module 119) that was part of the bladder cancer pathway [Zhang et al. DOI:10.1093/nar/gks725].